TY  - GEN
AU  - Umsawasdi,T
AU  - Valdivieso,M
AU  - Booser,D J
AU  - Barkley,H T
AU  - Ewer,M
AU  - MacKay,B
AU  - Dhingra,H M
AU  - Murphy,W K
AU  - Spitzer,G
AU  - Chiuten,D F
TI  - Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer
SN  - 0008-543X
PY  - 1989///1130
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Agranulocytosis
KW  - chemically induced
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Carcinoma, Squamous Cell
KW  - Cisplatin
KW  - administration & dosage
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Female
KW  - Heart
KW  - drug effects
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Myocardium
KW  - pathology
KW  - Prospective Studies
KW  - Random Allocation
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1002/1097-0142(19891115)64:10<1995::aid-cncr2820641004>3.0.co;2-l
ER  -